Skip to main content

BIO-TECHNE Corp income statement

  • TECH · Nasdaq
  • Biotechnology
  • Life Sciences Tools & Services
  • S&P 500
$72.80−0.05%Close 13 Nov 2026

BIO-TECHNE Corp reported revenue of $1.22 billion for fiscal year 2026 (the twelve months to 30 Jun 2026), down 0.4% from fiscal 2025. Net income was $182 million and diluted earnings per share $1.16.

From BIO-TECHNE Corp's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 30 Jun 2026. TTM is the last four reported quarters added up.

Annual

BIO-TECHNE Corp income statement, annual
USDFY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026TTM
Revenue$264.0M$269.0M$290.0M$314.6M$310.6M$357.8M$452.2M$499.0M$563.0M$643.0M$714.0M$738.7M$931.0M$1.11B$1.14B$1.16B$1.22B$1.22B$1.23B
Revenue growth—+1.9%+7.8%+8.5%−1.3%+15.2%+26.4%+10.3%+12.8%+14.2%+11.0%+3.5%+26.0%+18.7%+2.8%+2.0%+5.2%−0.4%—
Cost of revenue$55.92M$54.90M$65.03M$78.76M$79.47M$106.4M$145.0M$162.4M$188.5M$210.8M$240.5M$255.5M$298.2M$349.1M$366.9M$389.3M$429.4M$416.0M$420.6M
Gross profit$208.0M$214.1M$224.9M$235.8M$231.1M$251.4M$307.3M$336.7M$374.5M$432.1M$473.5M$483.2M$632.9M$756.5M$769.8M$769.7M$790.3M$799.1M$807.6M
Gross margin78.8%79.6%77.6%75.0%74.4%70.3%67.9%67.5%66.5%67.2%66.3%65.4%68.0%68.4%67.7%66.4%64.8%65.8%65.8%
Selling, general and administrative$33.69M$32.70M$35.90M$41.68M$43.38M$60.72M$119.4M$140.9M$200.4M$240.6M$264.4M$260.6M$325.0M$372.8M$378.4M$466.4M$588.5M$452.4M$469.9M
Operating expenses$57.25M$57.82M$61.88M$69.59M$72.64M$91.66M$160.3M$186.1M$254.0M$296.0M$326.8M$325.8M$395.6M$459.9M$470.9M$563.0M$688.0M$547.2M$566.7M
Operating income$150.8M$156.3M$163.1M$166.2M$158.5M$159.8M$147.0M$150.6M$120.6M$136.2M$146.7M$157.4M$237.3M$296.6M$298.9M$206.7M$102.3M$251.9M$240.8M
Operating margin57.1%58.1%56.2%52.8%51.0%44.7%32.5%30.2%21.4%21.2%20.5%21.3%25.5%26.8%26.3%17.8%8.4%20.7%19.6%
Interest expense————$0.00$0.00$1.54M$1.75M$7.36M$10.19M$21.70M$19.20M$13.95M$11.31M$11.21M$15.74M$8.51M$9.63M$8.87M
Other income and expense$4.58M$118.0K$1.93M−$4.01M$2.19M$1.64M$7.14M−$3.11M−$8.62M−$10.23M−$34.70M$119.1M−$89.12M$4.80M$39.72M−$21.00M−$3.79M−$11.21M−$13.45M
Income before tax—$156.4M$165.0M$162.2M$160.7M$161.4M$154.2M$147.5M$112.0M$126.0M$112.0M$276.5M$148.2M$301.4M$338.7M$185.7M$98.46M$240.7M$227.4M
Income tax expense$50.12M$46.67M$52.68M$49.86M$48.10M$50.44M$46.43M$43.01M$35.88M−$198.0K$15.94M$47.18M$8.59M$38.29M$53.22M$17.58M$25.06M$58.82M$55.41M
Effective tax rate—29.8%31.9%30.7%29.9%31.3%30.1%29.2%32.0%−0.2%14.2%17.1%5.8%12.7%15.7%9.5%25.5%24.4%24.4%
Net income$105.2M$109.8M$112.3M$112.3M$112.6M$110.9M$107.7M$104.5M$76.09M$126.2M$96.07M$229.3M$140.4M$272.1M$285.3M$168.1M$73.36M$181.8M$172.0M
Net margin39.9%40.8%38.7%35.7%36.2%31.0%23.8%20.9%13.5%19.6%13.5%31.0%15.1%24.6%25.1%14.5%6.0%15.0%14.0%
Net income to common shareholders———————$104.4M$76.02M$126.0M$95.97M$229.1M——$285.2M$168.1M$73.36M$181.8M$172.0M
EPS · diluted$0.69$0.73$0.76$0.76$0.76$0.75$0.72$0.70$0.51$0.83$0.62$1.45$0.87$1.66$1.76$1.05$0.46$1.16$1.09
Diluted weighted average shares152M149M149M148M148M148M149M149M150M152M156M158M162M164M162M161M160M157M157M
Basic weighted average shares151M149M148M148M147M148M148M149M149M150M151M153M155M157M157M158M158M156M156M
EBITDA$158.5M$164.5M$171.8M$178.7M$170.8M$178.9M$184.2M$193.4M$180.6M$200.6M$224.9M$240.2M$325.0M$397.7M$406.2M$318.4M$212.2M$349.2M$337.6M
EBITDA margin60.1%61.1%59.2%56.8%55.0%50.0%40.7%38.7%32.1%31.2%31.5%32.5%34.9%36.0%35.7%27.5%17.4%28.7%27.5%
Depreciation & amortization$7.77M$8.13M$8.70M$12.47M$12.32M$19.18M$37.23M$42.76M$60.04M$64.46M$78.17M$82.74M$87.75M$101.1M$107.2M$111.7M$109.9M$97.36M$96.75M
Stock-based compensation$1.50M$1.10M$1.10M—$1.86M$3.52M$5.96M$9.43M$14.63M$28.24M$32.28M$32.37M$48.98M$42.18M$39.23M$38.04M$40.83M$41.37M$43.09M
Dividends per share$0.19$0.26$0.27$0.28$0.29$0.31$0.32$0.32$0.32$0.32$0.32$0.32$0.32$0.80$0.32$0.32$0.32$0.32$0.32

Quarterly

BIO-TECHNE Corp income statement, quarterly
USDQ2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
Revenue$272.6M$303.4M$306.1M$289.5M$297.0M$316.2M$317.0M$286.6M$295.9M$311.4M$321.2M$299.7M
Cost of revenue$96.01M$98.83M$102.8M$106.4M$103.1M$101.6M$118.2M$98.44M$104.6M$103.1M$109.8M$103.1M
Gross profit$176.6M$204.6M$203.3M$183.0M$193.9M$214.6M$198.8M$188.1M$191.3M$208.3M$211.4M$196.6M
Gross margin64.8%67.4%66.4%63.2%65.3%67.9%62.7%65.6%64.6%66.9%65.8%65.6%
Selling, general and administrative$115.7M$111.8M$133.5M$119.2M$121.5M$151.3M$196.6M$116.2M$113.7M$109.3M$113.2M$133.7M
Operating expenses$138.6M$137.6M$157.5M$143.0M$146.5M$175.8M$222.7M$140.5M$136.8M$132.8M$137.1M$160.0M
Operating income$38.00M$67.00M$45.82M$39.99M$47.42M$38.71M−$23.86M$47.66M$54.46M$75.50M$74.28M$36.60M
Operating margin13.9%22.1%15.0%13.8%16.0%12.2%−7.5%16.6%18.4%24.2%23.1%12.2%
Interest expense$4.33M$4.00M$2.51M$2.18M$2.15M$2.01M$2.18M$2.93M$2.17M$2.40M$2.12M$2.17M
Other income and expense−$4.62M−$5.91M−$4.16M$184.0K−$4.54M−$434.0K$1.00M$333.0K−$3.68M−$4.27M−$3.60M−$1.91M
Income before tax$33.39M$61.08M$41.66M$40.17M$42.88M$38.27M−$22.86M$47.99M$50.78M$71.22M$70.68M$34.69M
Income tax expense$5.92M$12.03M$1.07M$6.57M$7.99M$15.69M−$5.18M$9.81M$12.78M$20.18M$16.06M$6.40M
Effective tax rate17.7%19.7%2.6%16.4%18.6%41.0%22.7%20.4%25.2%28.3%22.7%18.4%
Net income$27.46M$49.05M$40.58M$33.59M$34.89M$22.59M−$17.70M$38.18M$38.00M$51.04M$54.64M$28.29M
Net margin10.1%16.2%13.3%11.6%11.7%7.1%−5.6%13.3%12.8%16.4%17.0%9.4%
Net income to common shareholders$27.46M$49.05M$40.58M$33.59M$34.89M$22.59M−$17.70M$38.18M$38.00M$51.04M$54.64M$28.29M
EPS · diluted$0.17$0.31$0.25$0.21$0.22$0.14−$0.11$0.24$0.24$0.32$0.35$0.18
Diluted weighted average shares160M160M161M161M161M159M157M156M157M157M157M158M
Basic weighted average shares158M157M158M159M158M157M156M155M156M156M156M157M
EBITDA$65.81M$94.31M$73.88M$68.12M$74.50M$66.28M$3.25M$72.00M$79.17M$99.66M$98.42M$60.33M
EBITDA margin24.1%31.1%24.1%23.5%25.1%21.0%1.0%25.1%26.8%32.0%30.6%20.1%
Depreciation & amortization$27.80M$27.31M$28.06M$28.14M$27.08M$27.57M$27.11M$24.34M$24.71M$24.17M$24.14M$23.73M
Stock-based compensation$12.75M$8.13M$7.06M$10.18M$14.71M$11.39M$4.55M$11.68M$13.96M$10.49M$5.23M$13.41M
Dividends per share$0.08$0.08$0.08$0.08$0.08$0.08$0.08$0.08$0.08$0.08$0.08$0.08

The main figures as JSON and plain text. See data and methodology.

TECH in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.